Nadeem, O., Aranha, M. P., Redd, R., Timonian, M., Magidson, S., Lightbody, E. D., Alberge, J., Bertamini, L., Dutta, A. K., El-Khoury, H., Bustoros, M., Laubach, J. P., Bianchi, G., O’Donnell, E., Wu, T., Tsuji, J., Anderson, K. C., Getz, G., Trippa, L., Richardson, P. G., Sklavenitis-Pistofidis, R., Ghobrial, I. M. (2025). Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial. Nature Communications. https://doi.org/10.1038/s41467-024-55308-5